APHNX
Price
$17.83
Change
-$0.04 (-0.22%)
Updated
Sep 8 closing price
Net Assets
66.32M
VSTSX
Price
$307.13
Change
+$0.80 (+0.26%)
Updated
Sep 8 closing price
Net Assets
1.95T
Interact to see
Advertisement

APHNX vs VSTSX

Header iconAPHNX vs VSTSX Comparison
Open Charts APHNX vs VSTSXBanner chart's image
Artisan Select Equity Institutional
Price$17.83
Change-$0.04 (-0.22%)
VolumeN/A
Net Assets66.32M
Vanguard Total Stock Mkt Idx Instl Sel
Price$307.13
Change+$0.80 (+0.26%)
VolumeN/A
Net Assets1.95T
APHNX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.95T vs. APHNX (66.3M). VSTSX pays higher dividends than APHNX: VSTSX (1.17) vs APHNX (0.22). APHNX was incepted earlier than VSTSX: APHNX (6 years) vs VSTSX (9 years). APHNX (1.19) is less costly to investors than VSTSX (0.01). APHNX is a more actively managed with annual turnover of: 19.09 vs. VSTSX (2.00). APHNX has a lower initial minimum investment than VSTSX: APHNX (1000000) vs VSTSX (5000000000). APHNX annual gain was more profitable for investors over the last year : 19.08 vs. VSTSX (18.06). VSTSX return over 5 years is better than : 85.09 vs. APHNX (74.20).
APHNXVSTSXAPHNX / VSTSX
Total Expense Ratio1.110.0111,100%
Annual Report Gross Expense Ratio1.190.0111,900%
Fund Existence6 years9 years-
Gain YTD16.61210.361160%
Front LoadN/AN/A-
Min. Initial Investment100000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets66.3M1.95T0%
Annual Yield % from dividends0.221.1719%
Returns for 1 year19.0818.06106%
Returns for 3 years60.1663.7694%
Returns for 5 years74.2085.0987%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAUC15.020.77
+5.40%
Allied Gold Corp
AMBR3.980.20
+5.29%
Amber International Holding Limited
OSK139.570.45
+0.32%
Oshkosh Corp
WVVIP3.220.01
+0.31%
Willamette Valley Vineyards
HOWL1.35N/A
N/A
Werewolf Therapeutics